IMUX (Immunic) Cyclically Adjusted Book per Share: $230.06 (As of Mar. 2026)


IMUX Immunic Inc IMUX
32 GF Score
Price $15.15
! 3 Warning Signs
View Full Analysis

What is Immunic Cyclically Adjusted Book per Share?

Immunic IMUX +1.53% 32 Cyclically Adjusted Book per Share is $230.06 as of Mar. 2026. GuruFocus rates IMUX with a GF Score™ of 32/100. The stock has 3 warning signs investors should review.

E10 is a concept invented by Prof. Robert Shiller, who uses E10 for his Shiller PE Ratio calculation. E10 is the average of the inflation adjusted earnings of a company over the past 10 years. The similar calculation is applied by GuruFocus to calculate the Cyclically Adjusted Book per Share and the Cyclically Adjusted PB Ratio. The Cyclically Adjusted Book per Share is the average of the inflation adjusted Book Value per Share of a company over the past 10 years.

Immunic's adjusted book value per share for the three months ended in Mar. 2026 was $11.103. Add all the adjusted book value per share for the past 10 years together and divide the count will get our Cyclically Adjusted Book per Share, which is $230.06 for the trailing ten years ended in Mar. 2026.

During the past 12 months, Immunic's average Cyclically Adjusted Book Growth Rate was -36.10% per year. During the past 3 years, the average Cyclically Adjusted Book Growth Rate was -16.30% per year. Please click Growth Rate Calculation Example (GuruFocus) to see how GuruFocus calculates Wal-Mart Stores Inc (WMT)'s revenue growth rate. You can apply the same method to get the Cyclically Adjusted Book Growth Rate using Cyclically Adjusted Book per Share data.

During the past 13 years, the highest 3-Year average Cyclically Adjusted Book Growth Rate of Immunic was -16.30% per year. The lowest was -16.30% per year. And the median was -16.30% per year.

As of today (2026-06-27), Immunic's current stock price is $15.15. Immunic's Cyclically Adjusted Book per Share for the quarter that ended in Mar. 2026 was $230.06. Immunic's Cyclically Adjusted PB Ratio of today is 0.07.

During the past 13 years, the highest Cyclically Adjusted PB Ratio of Immunic was 0.07. The lowest was 0.00. And the median was 0.00.


Immunic  (NAS:IMUX) Cyclically Adjusted Book per Share Explanation

If a company grows much fast than inflation, Cyclically Adjusted Book per Share may underestimate the company's equity. Cyclically Adjusted PB Ratio can seem to be too high even the actual PB Ratio is low.

For the Cyclically Adjusted PB Ratio, the book value of the past 10 years are inflation-adjusted and averaged. The result is used for P/B calculation. Since it looks at the average over the last 10 years, the Cyclically Adjusted PB Ratio is also called CAPB Ratio.

The Shiller PE Ratio was first used by professor Robert Shiller. He uses E10 for his Shiller PE Ratio calculation. E10 is the average of the inflation adjusted earnings per share of a company over the past 10 years. The similar calculation is applied by GuruFocus to calculate the Cyclically Adjusted PB Ratio. The Cyclically Adjusted Book per Share is the average of the inflation adjusted book value per share of a company over the past 10 years.

Immunic's Cyclically Adjusted PB Ratio of today is calculated as

Cyclically Adjusted PB Ratio=Share Price/Cyclically Adjusted Book per Share
=15.15/230.06
=0.07

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

During the past 13 years, the highest Cyclically Adjusted PB Ratio of Immunic was 0.07. The lowest was 0.00. And the median was 0.00.


Be Aware

Cyclically Adjusted PB Ratio works better for cyclical companies. It gives you a better idea on the company's real book value.


Immunic Cyclically Adjusted Book per Share Related Terms


Immunic Cyclically Adjusted Book per Share Historical Data

* Premium members only.

The historical data trend for Immunic's Cyclically Adjusted Book per Share can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Immunic Cyclically Adjusted Book per Share Chart

Immunic Annual Data
Trend Dec16 Dec17 Dec18 Dec19 Dec20 Dec21 Dec22 Dec23 Dec24 Dec25
Cyclically Adjusted Book per Share
Get a 7-Day Free Trial Premium Member Only Premium Member Only 0.00 443.69 511.46 406.77 259.98

Immunic Quarterly Data
Jun21 Sep21 Dec21 Mar22 Jun22 Sep22 Dec22 Mar23 Jun23 Sep23 Dec23 Mar24 Jun24 Sep24 Dec24 Mar25 Jun25 Sep25 Dec25 Mar26
Cyclically Adjusted Book per Share Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only 364.88 328.84 297.78 259.98 230.06

IMUX vs KPTI, INDP, UNCY: Cyclically Adjusted Book per Share Comparison

For the Biotechnology subindustry, Immunic's Cyclically Adjusted PB Ratio, along with its competitors' market caps and Cyclically Adjusted PB Ratio data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.


Immunic Cyclically Adjusted PB Ratio vs Biotechnology Industry

For the Biotechnology industry and Healthcare sector, Immunic's Cyclically Adjusted PB Ratio distribution charts can be found below:

* The bar in red indicates where Immunic's Cyclically Adjusted PB Ratio falls into.


IMUX
32GF Score
Immunic Inc IMUX
Cyclically Adjusted Book per Share is just one metric. See GF Score™, valuation, warning signs, and more.
View Full Analysis

Immunic Cyclically Adjusted Book per Share Calculation

E10 is a concept invented by Prof. Robert Shiller, who uses E10 for his Shiller PE Ratio calculation. E10 is the average of the inflation adjusted earnings of a company over the past 10 years. The similar calculation is applied by GuruFocus to calculate the Cyclically Adjusted Book per Share and the Cyclically Adjusted PB Ratio. The Cyclically Adjusted Book per Share is the average of the inflation adjusted Book Value per Share of a company over the past 10 years.

What is Cyclically Adjusted Book per Share? How do we calculate Cyclically Adjusted Book per Share?

Cyclically Adjusted Book per Share is the average of the inflation adjusted Book Value per Share of a company over the past 10 years. Let's use an example to explain.

If we want to calculate the Cyclically Adjusted Book per Share of Wal-Mart (WMT) for Dec. 31, 2010, we need to have the inflation data and the book value per share from 2001 through 2010.

We adjusted the 2001 book value per share data with the total inflation from 2001 through 2010 to the equivalent book value in 2010. If the total inflation from 2001 to 2010 is 40%, and Wal-Mart's book value is $1 a share in 2001, then the 2001's equivalent book value in 2010 is $1.4 a share. If Wal-Mart's book value is $1 again in 2002, and the total inflation from 2002 through 2010 is 35%, then the equivalent 2002 book value in 2010 is $1.35. So on and so forth, you get the equivalent book value per share of past 10 years. Then you add them together and divided the sum by the count to get Cyclically Adjusted Book per Share.

Please note that we use the CPI data of the country/region where the company is headquartered. If the CPI data for that country/region is not available, then we will use the CPI data of the United States as default.

For example, Immunic's adjusted Book Value per Share data for the three months ended in Mar. 2026 was:

Adj_Book= Book Value per Share /CPI of Mar. 2026 (Change)*Current CPI (Mar. 2026)
=11.103/330.2130*330.2130
=11.103

Current CPI (Mar. 2026) = 330.2130.

Immunic Quarterly Data

Book Value per Share CPI Adj_Book
201606 938.570 241.018 1,285.912
201609 847.000 241.428 1,158.484
201612 730.575 241.432 999.227
201703 796.491 243.801 1,078.797
201706 691.858 244.955 932.663
201709 585.642 246.819 783.516
201712 472.113 246.524 632.384
201803 351.840 249.554 465.559
201806 249.557 251.989 327.026
201809 134.453 252.439 175.877
201812 117.236 251.233 154.091
201903 85.368 254.202 110.895
201906 69.480 256.143 89.572
201909 60.106 256.759 77.301
201912 54.342 256.974 69.830
202003 46.662 258.115 59.696
202006 52.562 257.797 67.327
202009 78.608 260.280 99.729
202012 75.005 260.474 95.087
202103 63.194 264.877 78.782
202106 55.514 271.696 67.470
202109 55.415 274.310 66.708
202112 48.259 278.802 57.158
202203 47.182 287.504 54.191
202206 41.835 296.311 46.621
202209 35.605 296.808 39.612
202212 28.920 296.797 32.176
202303 20.545 301.836 22.477
202306 15.573 305.109 16.854
202309 10.854 307.789 11.645
202312 6.403 306.746 6.893
202403 9.278 312.332 9.809
202406 7.057 314.175 7.417
202409 4.576 315.301 4.792
202412 2.044 315.605 2.139
202503 -0.586 319.799 -0.605
202506 3.438 322.561 3.520
202509 1.064 324.800 1.082
202512 -0.554 324.054 -0.565
202603 11.103 330.213 11.103

Add all the adjusted book value per share together and divide the count will get our Cyclically Adjusted Book per Share.

What does a Cyclically Adjusted Book per Share of $230.06 mean?
Immunic (IMUX) has a Cyclically Adjusted Book per Share of $230.06 as of Mar. 2026. Cyclically adjusted book value per share represents the company's inflation-adjusted book value per share over a 10-year period. View historical data on Immunic and its competitors.
Is Immunic's Cyclically Adjusted Book per Share too high?
Immunic's current Cyclically Adjusted Book per Share is $230.06. Overall, Immunic has a GF Score™ of 32/100, reflecting its overall financial health beyond just this single metric.
How does Immunic's Cyclically Adjusted Book per Share compare to KPTI and INDP?
Immunic's Cyclically Adjusted Book per Share of $230.06 can be compared against companies in the Biotechnology industry. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good Cyclically Adjusted Book per Share for a Biotechnology company?
A good Cyclically Adjusted Book per Share depends on the Biotechnology industry context. However, Cyclically Adjusted Book per Share should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high Cyclically Adjusted Book per Share mean?
A high Cyclically Adjusted Book per Share can signal that a stock is expensive relative to its fundamentals. Cyclically adjusted book value per share represents the company's inflation-adjusted book value per share over a 10-year period. View historical data on Immunic and its competitors. Immunic's current Cyclically Adjusted Book per Share is $230.06. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is Immunic stock overvalued right now?
Immunic (IMUX) has a current Cyclically Adjusted Book per Share of $230.06. The current Cyclically Adjusted Book per Share is $230.06. Immunic's overall GF Score™ is 32/100 with 3 warning signs to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is Cyclically Adjusted Book per Share calculated?
Cyclically Adjusted Book per Share is calculated from a company's financial statements. For Immunic (IMUX), the current Cyclically Adjusted Book per Share is $230.06 as of Mar. 2026. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.

Immunic Business Description

Other Exchanges 10V:Germany
Address 1200 Avenue of the Americas, Suite 200, New York, NY, USA, 10036
Immunic Inc is a clinical-stage biopharmaceutical company developing a pipeline of selective oral immunology therapies aimed at treating chronic inflammatory and autoimmune diseases, including ulcerative colitis, Crohn's disease, relapsing-remitting multiple sclerosis, and psoriasis. The company is developing small molecule products, which include IMU-838, which is a selective immune modulator that inhibits the intracellular metabolism of activated immune cells by blocking the enzyme DHODH; IMU-935 is an inverse agonist of RORyt, and IMU-856 targets the restoration of the intestinal barrier function. It operates in one segment which is Life science segment.
32GF Score

Get the complete analysis for IMUX

Cyclically Adjusted Book per Share is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.

$15.15
Price